The Beachbody Company (BODY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
18 May, 2026Mission and market opportunity
Mission is to help people achieve their goals and lead healthier, more fulfilling lives through nutrition and fitness tools.
Over 32 million customers served and $12.5+ billion in revenue since inception.
Operates in the $6.5 trillion global wellness industry, with fitness and nutrition representing a $2.2 trillion opportunity.
27+ years of innovation in fitness and nutrition, with a strong portfolio of iconic brands.
Business transformation and turnaround
Transitioned from MLM to a multi-channel model, exiting MLM in December 2024 and expanding into DTC, Amazon, affiliate, and retail channels.
Reduced headcount from over 1,000 to under 300 in four years, increasing organizational agility.
Adjusted EBITDA breakeven revenue reduced from $900 million to $180 million in less than three years.
Refinanced debt from $50 million to $25 million, cutting interest rate from 28% to 14.8%.
Financial performance and milestones
Achieved 10 consecutive quarters of positive Adjusted EBITDA totaling $69.8 million.
Reported full-year operating income and positive net income in 2025 for the first time since IPO.
Free cash flow positive in 2025, with significant improvements in net income and adjusted net income.
Revenue breakeven reduced by $720 million from 2022 to 2025.
Cash position at $36.6 million and debt at $25 million as of March 31, 2026.
Latest events from The Beachbody Company
- Turnaround success and retail expansion set the stage for accelerated growth in 2027.BODY
Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference3 Jun 2026 - Turnaround success: multi-channel strategy, retail launches, and 10 straight profitable quarters.BODY
16th Annual LD Micro Invitational Conference21 May 2026 - Third consecutive profitable quarter with $2.3M net income, margin gains, and retail expansion.BODY
Q1 202612 May 2026 - Board recommends approval of director slate, auditor, and executive compensation at annual meeting.BODY
Proxy filing23 Apr 2026 - Virtual annual meeting to vote on board, auditor, and executive pay, with board support for all.BODY
Proxy filing23 Apr 2026 - Turnaround success with new multi-channel strategy, strong financials, and innovative product launches.BODY
Investor presentation24 Mar 2026 - Achieved profitability, positive cash flow, and launched new products despite revenue decline.BODY
Q4 202510 Mar 2026 - Turnaround strategy leverages hybrid sales, cost cuts, and innovation to drive profitable growth.BODY
Virtual Consumer Company Showcase3 Feb 2026 - Q2 beat guidance with improved margins, positive cash flow, and a shift toward nutrition growth.BODY
Q2 20242 Feb 2026